Cresco Labs (CRLBF) Income from Continuing Operations (2020 - 2026)
Cresco Labs (CRLBF) reported Income from Continuing Operations of 11426000.0 for Q1 2026, down 14.72% on a YoY basis from 13398000.0 in Q1 2025, and up 113.39% quarter-over-quarter from 85341000.0 in Q4 2025.
Cresco Labs (CRLBF) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Cresco Labs has reported Income from Continuing Operations for 7 years, with the latest figure at 11426000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations fell 14.72% year-over-year to 11426000.0; the trailing twelve-month figure through Mar 2026 stood at 52770000.0 (down 382.13% YoY), and the FY2025 full-year result was 140044000.0, down 131.52% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 11426000.0, up from 85341000.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 38980000.0 in Q2 2022, with the low at 133101000.0 in Q4 2022.
- Historically, Income from Continuing Operations has averaged 8943176.47 across 5 years, with a median of 11426000.0 in 2026.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations soared 484.76% — and 2025, when it slumped 1604.87%.
- Cresco Labs' Income from Continuing Operations stood at 133101000.0 in 2022, then surged by 115.6% to 20768000.0 in 2023, then slumped by 72.69% to 5671000.0 in 2024, then tumbled by 1604.87% to 85341000.0 in 2025, then jumped by 113.39% to 11426000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 11426000.0 (Q1 2026), 85341000.0 (Q4 2025), and 1766000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 21.05 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Cresco Labs | - | - | 75.45 Mn | 11.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 11.43 Mn |
| Dec 31, 2025 | -85.34 Mn |
| Sep 30, 2025 | 1.77 Mn |
| Jun 30, 2025 | 19.38 Mn |
| Mar 31, 2025 | 13.40 Mn |
| Dec 31, 2024 | 5.67 Mn |
| Sep 30, 2024 | 30.34 Mn |
| Jun 30, 2024 | -30.70 Mn |
| Mar 31, 2024 | 33.95 Mn |
| Dec 31, 2023 | 20.77 Mn |
| Sep 30, 2023 | -124.94 Mn |
| Jun 30, 2023 | -15.59 Mn |
| Mar 31, 2023 | 5.81 Mn |
| Dec 31, 2022 | -133.10 Mn |
| Sep 30, 2022 | 34.22 Mn |
| Jun 30, 2022 | 38.98 Mn |
| Mar 31, 2022 | 21.94 Mn |
| Dec 31, 2021 | 35.15 Mn |
| Sep 30, 2021 | -288.27 Mn |
| Jun 30, 2021 | 29.58 Mn |